DuPont de Nemours Inc vs KKR & Co Inc — how do they compare? DuPont de Nemours Inc trades at $144.14 (market cap $19.51B), while KKR & Co Inc trades at $110.51 (market cap $99.61B). The key difference: KKR & Co Inc is far larger — about 5.1× DuPont de Nemours Inc's market cap, and DuPont de Nemours Inc pays the higher dividend (1.66%). Which is the better fit depends on your goals.
| DD | KKR | |
|---|---|---|
Market Cap | $19.51B | $99.61B |
Sector | Basic Materials | Financials |
52-Week High | $154.59 | $149.34 |
52-Week Low | $90.24 | $83.88 |
Enterprise Value | $20.90B | $22.17B |
Dividend Yield | 1.66% | 0.7% |
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $143.64, up 1.47% today, with strong technical momentum as price approaches resistance near $146. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $1.88 exceeding the $1.76 estimate, and raised full-year 2026 guidance. Recent news highlights contract wins in water treatment and R&D innovation awards, though the stock faces valuation concerns with a P/E of 62 and negative net income in 2025.
The outlook is cautiously optimistic given earnings momentum and analyst bullishness (58% buy ratings), but high valuation and thin profit margins pose risks. The consensus price target of $232.80 suggests significant upside if execution continues, though investors should monitor debt levels and PFAS litigation developments that could impact financials.
KKR's stock trades at $110.37, up 6.3% today, showing strong momentum near recent highs. The technical outlook is bullish with the price above key moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, the company reported Q2 2026 EPS of $1.63, beating estimates of $1.43, with revenue growth supported by recent acquisitions including Integer Holdings and Medicover India. Analyst sentiment remains overwhelmingly positive with 24 buy ratings and a $127.22 consensus price target.
KKR presents a compelling investment case with strong earnings momentum, strategic acquisitions expanding its healthcare and infrastructure portfolios, and robust analyst support. However, risks include execution challenges from recent M&A activity, potential market volatility affecting asset valuations, and the stock's current premium valuation multiples. The company's ability to integrate acquisitions and maintain fundraising momentum will be key drivers of future performance.
Trailing returns across standard periods
Latest headlines on both assets
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.
Read more on KKR →